Man Group
RNAC icon

Man Group’s Cartesian Therapeutics RNAC Stock Holding History

Man Group’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$146K Buy
+23,699
New +$169K ﹤0.01% 2330
2023
Q1 		– Sell
-5,206
Closed -$245K – 1719
2022
Q4 		$176K Buy
5,206
+667
+15% +$28.4K ﹤0.01% 1800
2022
Q3 		$223K Buy
+4,539
New +$249K ﹤0.01% 1746
2022
Q2 		– Hold
0
– – – 1940
2022
Q1 		– Sell
-6,000
Closed -$587K – 2335
2021
Q4 		$587K Buy
6,000
+20
+0.3% +$2.15K ﹤0.01% 1483
2021
Q3 		$746K Buy
5,980
+799
+15% +$96.5K ﹤0.01% 1436
2021
Q2 		$650K Sell
5,181
-1,891
-27% -$225K ﹤0.01% 1494
2021
Q1 		$960K Sell
7,072
-2,444
-26% -$303K ﹤0.01% 1302
2020
Q4 		$865K Buy
9,516
+1,669
+21% +$145K ﹤0.01% 1449
2020
Q3 		$584K Buy
7,847
+3,069
+64% +$235K ﹤0.01% 1518
2020
Q2 		$407K Buy
4,778
+3,491
+271% +$316K ﹤0.01% 1500
2020
Q1 		$93K Sell
1,287
-27,418
-96% -$2.65M ﹤0.01% 1521
2019
Q4 		$2.05M Sell
28,705
-92,418
-76% -$4.46M 0.01% 1325
2019
Q3 		$6.36M Sell
121,123
-763
-0.6% -$40.5K 0.02% 759
2019
Q2 		$6.54M Buy
121,886
+217
+0.2% +$14.8K 0.02% 840
2019
Q1 		$8.65M Buy
121,669
+103,854
+583% +$6.58M 0.03% 655
2018
Q4 		$1.42M Buy
17,815
+9,238
+108% +$2.11M 0.01% 1340
2018
Q3 		$4M Buy
8,577
+4,989
+139% +$2M 0.01% 1113
2018
Q2 		$1.43M Buy
+3,588
New +$1.27M 0.01% 1492

Other funds holding RNAC

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Man Group's RNAC Position: Q1 2026 in Review

Man Group opened a new position in Cartesian Therapeutics (RNAC) in Q1 2026: 23,699 shares worth $146K. The stake represents ﹤0.01% of the portfolio and ranks #2330 among its holdings. This is a return to the name: Man Group previously reported a position in RNAC as recently as Q4 2022.

Man Group first reported a position in RNAC in Q2 2018 and has held it in 18 quarters since. The position peaked at $8.65M in Q1 2019. 83 funds tracked by Wall St. Rank hold RNAC as of Q1 2026.

  • Man Group held 23,699 shares of Cartesian Therapeutics worth $146K as of Q1 2026.
  • Cartesian Therapeutics was a new Man Group position in Q1 2026.
  • Cartesian Therapeutics made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2330 holding.
  • Man Group first reported a position in Cartesian Therapeutics in Q2 2018 and has held it in 18 quarters since.
  • Man Group's Cartesian Therapeutics position peaked at $8.65M in Q1 2019.
  • 83 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.